Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Managing the pharmacy benefit in Medicare HMOs: what do we really know?

Lipton HL, Gross DJ, Stebbins MR, Syed LH.

Health Aff (Millwood). 2000 Mar-Apr;19(2):42-58.

PMID:
10718021
2.

Designing a Medicare prescription drug benefit: issues, obstacles, and opportunities.

McClellan M, Spatz ID, Carney S.

Health Aff (Millwood). 2000 Mar-Apr;19(2):26-41. Review.

PMID:
10718020
3.

Kaiser Permanente's prescription drug benefit.

Levine S, Campen D, Millares M, Barrueta A.

Health Aff (Millwood). 2000 Mar-Apr;19(2):185-90. Review. No abstract available.

PMID:
10718032
4.

Just what the HMO ordered: the paradox of increasing drug costs.

Kleinke JD.

Health Aff (Millwood). 2000 Mar-Apr;19(2):78-91. Review.

PMID:
10718024
5.
6.
7.

The Medicare prescription drug benefit: how will the game be played?

Huskamp HA, Rosenthal MB, Frank RG, Newhouse JP.

Health Aff (Millwood). 2000 Mar-Apr;19(2):8-23. Review.

PMID:
10718018
8.

Medicare Part D: practical practice information for healthcare providers.

Moczygemba LR.

J Am Acad Nurse Pract. 2006 Oct;18(10):457-62. Review.

PMID:
16999710
9.

The role of PBMs in implementing the Medicare prescription drug benefit.

Atlas RF.

Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-504-15. Review.

PMID:
15513957
10.

Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit.

Brill JV.

Am J Health Syst Pharm. 2007 Aug 1;64(15 Suppl 10):S3-6; quiz S21-S23. Review.

PMID:
17646551
11.

Navigating the new Medicare drug benefit.

Stuart B.

Am J Geriatr Pharmacother. 2004 Mar;2(1):75-80. Review.

PMID:
15555481
12.

Government and private insurance medical programs as well as MDVIP, an update.

Edlich RF, Winters KL, Brit LD, Long WB.

J Long Term Eff Med Implants. 2004;14(3):243-50. Review.

PMID:
15301667
13.

Prescription drugs in Medicare and the ESRD program.

Powe NR.

Semin Nephrol. 2000 Nov;20(6):535-42. Review.

PMID:
11111855
14.
15.
16.

Health maintenance organizations in developing countries: what can we expect?

Tollman S, Schopper D, Torres A.

Health Policy Plan. 1990;5(2):149-60. Review.

PMID:
10106761
17.

Improving diabetes care for Medicare beneficiaries in outpatient setting: follow-up report.

Blustein JN, Gold JA, Miesbauer KM, Halvorsen CL.

WMJ. 1998 Mar;97(3):62-6. Review. No abstract available.

PMID:
9540453
18.

Pharmacy benefit managers: evaluating clinical utility in the real world.

Epstein RS.

Clin Pharmacol Ther. 2010 Dec;88(6):880-2. doi: 10.1038/clpt.2010.216. Epub 2010 Oct 20. Review.

PMID:
20962775
19.

Pharmacy benefit management companies: dimensions of performance.

Lipton HL, Kreling DH, Collins T, Hertz KC.

Annu Rev Public Health. 1999;20:361-401. Review.

PMID:
10352863
20.

Improved stakeholder management: the key revitalizing the HMO movement?

Topping S, Fottler MD.

Med Care Rev. 1990 Fall;47(3):365-93. Review.

PMID:
10108050

Supplemental Content

Support Center